Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 2, 2008
Adverse mood effects of combined oral contraceptives in relation to personality traitsAnna Borgström, Viveca Odlind, Lisa Ekselius, et al.Ecological Applications : a Publication of the Ecological Society of America|January 29, 2024
Wetlands as a potential multifunctioning tool to mitigate eutrophication and brownificationAnna Borgström, Lars-Anders Hansson, Clemens Klante, et al.Seminars in Cell & Developmental Biology|January 11, 2019
Store-operated calcium entry in disease: Beyond STIM/Orai expression levelsSven Kappel, Anna Borgström, Paulina Stokłosa, et al.JAMA Otolaryngology-- Head & Neck Surgery|September 18, 2025
Adenotonsillectomy vs Watchful Waiting in Pediatric Mild to Moderate Obstructive Sleep Apnea: The KATE Randomized Clinical TrialIsabella Sjölander, Johan Fehrm, Anna Borgström, et al.Laryngoscope Investigative Otolaryngology|December 22, 2022
Correlations between objective and subjective outcomes after adenotonsillar surgery in children with OSAIsabella Sjölander, Anna Borgström, Pia Nerfeldt, et al.Cancers|November 13, 2021
Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer CellsPaulina Stokłosa, Anna Borgström, Barbara Hauert, et al.BMJ Open|January 15, 2017
Trends and changes in paediatric tonsil surgery in Sweden 1987-2013: a population-based cohort studyAnna Borgström, Pia Nerfeldt, Danielle Friberg, et al.Psychoneuroendocrinology|March 11, 2008
Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controlsAnna Borgström, Kristiina Kask, Maria Gulinello, et al.Contraception|December 2, 2008
Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptivesBirgitta Segebladh, Anna Borgström, Viveca Odlind, et al.American Journal of Obstetrics and Gynecology|April 29, 2009
Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorderBirgitta Segebladh, Anna Borgström, Sigrid Nyberg, et al.Pageof 3